GlassScriptPhysician profile
Michael Monroe Jugan
NPI 1396706966
$29,456.38
in general payments reported to CMS, 2019-2025
24 companies · $7,112 in 2025
The $7,112 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $146 · 2021: $148 · 2022: $29.92 · 2023: $12K · 2024: $10K · 2025: $7,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $28K · Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $27,750.45 |
| Food and Beverage | $1,265.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $27,767.07 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $294.69 | 2020-2024 | Variax, Gamma, Axsos |
| Bioventus LLC | $163.59 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Djo, LLC | $161.70 | 2020-2025 | Cmf |
| Smith+Nephew, INC. | $156.44 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Amgen INC. | $140.43 | 2020-2025 | Evenity, Prolia |
| Vertex Pharmaceuticals Incorporated | $120.10 | 2025 | |
| Heron Therapeutics, INC. | $94.19 | 2021 | |
| Orthalign INC | $93.72 | 2025 | Orthalign Plus |
| Ossur Americas, INC. | $62.04 | 2025 | Unloader One X |
| Solventum Corporation | $50.02 | 2024-2025 | Promogran Prisma, Activ.A.C. |
| Pacira Pharmaceuticals Incorporated | $47.32 | 2025 | Exparel |
| Radius Health, INC. | $42.90 | 2019-2022 | |
| Fidia Pharma USA INC. | $31.06 | 2020-2024 | Hym/Hyn |
| Pfizer INC. | $30.12 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $26.73 | 2025 | Puraply Wound Matrix |
| Si-Bone, INC. | $24.82 | 2025 | |
| Axogen | $24.42 | 2025 | |
| Vericel Corporation | $23.76 | 2025 | Maci |
| Ferring Pharmaceuticals INC. | $22.62 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.95 | 2019 | |
| Heraeus Medical, LLC. | $19.85 | 2024 | |
| Depuy Synthes Sales INC. | $19.73 | 2019 | |
| Ermi LLC | $19.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jugan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.